Award Amount: £114,820
Award Duration: 12 months
Background: Arterial GlucoSave is a patient safety solution to eliminate the common error of incorrect fluids being administered as the flush solution prior to blood sampling from an arterial line in the critical care setting.
A sodium chloride solution is the recommended flush solution but can often be confused with glucose-containing bags. This can result in artefactually high glucose concentrations in blood samples drawn from the arterial line leading to insulin administration causing hypoglycaemia and fatal neuroglycopenic brain injury.
The Arterial GlucoSave technology designs out this error. 6.4 million arterial blood gas samples are taken in the UK per year.
Project Plan for Award: The award will be used to take early prototypes through to a CE marked medical device ready for market.
“ Receiving support from the Medtech Accelerator is fantastic and has meant that we can make a start and speed up the progress of our innovation project in a very meaningful way”
Dr Maryanne Mariyaselvam
MD Research Student, University of Cambridge
Clinical Research Fellow, Division of Anaesthesia
Cambridge University Teaching Hospitals and the Queen Elizabeth Hospital, Kings Lynn